Silverstein M N
Postgrad Med. 1977 Jan;61(1):212-6. doi: 10.1080/00325481.1977.11714522.
Chronic lymphocytic leukemia and chronic granulocytic leukemia vary considerably in their clinical features, laboratory findings, and therapy, but both generally have an ominous prognosis. Chemotherapy remains the mainstay of treatment in both disorders, with adjunctive measures to control complications such as anemia and splenomegaly. Immunotherapy for granulocytic leukemia is still under study but appears promising.
慢性淋巴细胞白血病和慢性粒细胞白血病在临床特征、实验室检查结果及治疗方面有很大差异,但两者的预后通常都不容乐观。化疗仍然是这两种疾病治疗的主要手段,并辅以控制贫血和脾肿大等并发症的措施。针对粒细胞白血病的免疫疗法仍在研究中,但前景看好。